Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)

Liu, 2014, Activated STING in a vascular and pulmonary syndrome, N Engl J Med, 371, 507, 10.1056/NEJMoa1312625 Crow, 2014, STING-associated vasculopathy with onset in infancy—a new interferonopathy, N Engl J Med, 371, 568, 10.1056/NEJMe1407246 Rice, 2013, Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, Lancet Neurol, 12, 1159, 10.1016/S1474-4422(13)70258-8 Picard, 2015, Inherited anomalies of innate immune receptors in pediatric-onset inflammatory diseases, Autoimmun Rev, 14, 1147, 10.1016/j.autrev.2015.08.002 Jeremiah, 2014, Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations, J Clin Invest, 124, 5516, 10.1172/JCI79100 Devine, 2012, Genetic interstitial lung disease, Clin Chest Med, 33, 95, 10.1016/j.ccm.2011.11.001 Silhan, 2014, Lung transplantation in telomerase mutation carriers with pulmonary fibrosis, Eur Respir J, 44, 178, 10.1183/09031936.00060014 Borie, 2015, Severe hematologic complications after lung transplantation in patients with telomerase complex mutations, J Heart Lung Transplant, 34, 538, 10.1016/j.healun.2014.11.010